Skip to main content

A REVIEW ON USFDA WARNING LETTER AND VIOLATION OBSERVED IN PHARMACEUTICAL INDUSTRY

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Suleman S. khoja 1, Sohil S khoja
1,Parthkumar H chauhan 2,Farhad S Khoja
1Resource person in pharmaceutical quality assurance ,VAPI, Gujarat.
2Resource person in quality assurance ,NAVSARI, Gujarat.
3Registered Pharmacist ,VAPI, Gujarat.
premukhoja@gmail.com

ABSTRACT
A review on USFDA observation and finding while inspection of Pharmaceutical the present review provide some important , Significant observation and measure of compliance.USFDA is an regulatory body governing health products which are made ( in or  outside USA) and marketed in united States of America. Significant deviation from cGMP and Significant violation from cGMP for both API Facility and formulations .strictly compliance requirements under 21 Code of federal regulations (CFR). FDA observation includes but not limited to this. If not cleaned and maintained equipment at appropriate intervals to prevent contamination that would alter the Safety, Identity, Strength, Purity and Quality of drug product (SISPQ) ,violation under [ 21 CFR & 211.67 (a) ]. Data integrity is main issue Raised in most FDA warning letter. Corrective action and plan. Level of control must be raised from raw material, packaging material (Accurate, Legible, Contamptarious, Original, Attributable (ALCOA)) in process, finished dosage form, Maintain log book properly. Guidelines for Out of specification(OOS ) and out of trends(OOT)  must be follow if any required.

Applications are invited for Pharmacist, Staff Nurse at IPHB

Applications are invited by the Director/Dean, I.P.H.B., Bambolim-Goa for recruitment to the following posts in this Institute from the suitable candidates. They should clearly indicate their name, address, nationality, date of birth, experience, employment registration number, 15 years of residence certificate in Goa and other essential certificates issued by the competent authority. The application should be accompanied with attested copies of the relevant documents to reach in the office of the Director/Dean, Institute of Psychiatry & Human Behaviour, Opp. Holy Shrine of Holy Cross, Bambolim - Goa on or before 20/07/2016.

Post : Staff Nurse, Pharmacist

Working opportunity for Pharmacist in Sahyadri Hospitals, Pune | 02 Posts

Sahyadri Hospitals is the largest chain of hospitals in Mahrashtra. It is always within easy reach due to its strategic locations which include cities like Pune, Nashik, Karad and Navi Mumbai.
Sahyadri group has 10 Hospitals with more than 860 beds currently and plans to expand to almost 1200 beds by end of the next financial year. Sahyadri has touched the lives of over 10 lakh people by providing quality care.

vacancy as Assistant Professors in Shri Ram College of Pharmacy

ShriRam College of pharmacy (SRCP) has been established by "Dayal Seva Evam Shiksha Samiti, Morena" in 2003, with the view to provide excellence in pharmacy education and to create an environment for blooming of pharmacy professionals. ShriRam College of Pharmacy is a part of the Shriram Group of Colleges comprising of Shriram College of Engineering and Management and SRIIT. The parent institute, established in 1998 and the  Pharmacy college is nurtured with care under the protective umbrella of the Dayal Seva Evam Shiksha Samiti.

Novartis looking for Health Registration Executive

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Health Registration Executive

Applications are invited for Professors, Associate Professors & Assistant Professors at Baddi University

Baddi University of Emerging Sciences and Technologies, formerly the Institute of Engineering and Emerging Technologies, is a private technical and professional higher education institution located at Baddi, Himachal Pradesh, India.

Applications are invited for the following positions for UG/PG Courses

Post : Professors, Associate Professors & Assistant Professors

Inviting for post of Area Sales Manager in Baxter

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2012 sales of $14.2 billion and has approximately 50,800 employees.

Post : Area Sales Manager - 160004E9

Bacteria are rapidly developing resistance mechanisms to combat even the most effective antibiotics. Each year in the United States over 23,000 people die as a result of bacterial infections that have no treatment options, according to the Centers for Disease Control. Infections with antibiotic-resistance bacteria are extremely difficult to treat, requiring costly or toxic medications that do not always work. Scientists are constantly working to understand the mechanisms bacteria use to outsmart antibiotics and develop resistance. These mechanisms include metallo-β-lactamases (MBLs), enzymes produced by bacteria that can bind to and inactivate antibiotics. Enzymes like MBLs are one way bacteria are defying all available tools and becoming antibiotic resistant.

Job in QC, QA, Manufacturing of Zydus Cadila - Walk in interview | Only Exp candidates

Zydus Cadila is one of India's leading healthcare companies and a global healthcare provider with strengths all along the pharmaceutical value chain. The group’s state-of-the-art manufacturing infrastructure is spread across five states of Gujarat, Maharasahtra, Goa, Himachal Pradesh and Sikkim and the R&D Centers are spread across Ahmedabad, Baroda and Mumbai (Thane).

Post:Officer/Executive / Senior Executive / Assistant  Manager/Deputy Manager

Abbvie announced that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Disease Designation for ABT-414, an investigational antibody drug conjugate (ADC) targeting the epidermal growth factor receptor (EGFR), for the treatment of pediatric patients with EGFR-amplified Diffuse Intrinsic Pontine Glioma (DIPG), known to be highly aggressive and difficult to treat brain tumors found at the base of the brain.